Tuesday, October 13, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 15.3
NASDAQ 100 breadth is bifurcated: mega-cap tech and select software/AI names (MSFT, META, AAPL, PLTR, SHOP, FTNT) are grinding within a few percent of 52-week highs with consistent 5-day and 30-day gains, while semiconductor equipment, memory/storage, and telecom names (LRCX, AMAT, KLAC, WDC, STX, SNDK, CMCSA, TMUS) are down sharply and far from highs. Defensive consumer staples and services (WMT, COST, KDP, CTAS) are quietly trending higher, suggesting some rotation into safety. Overall setup favors selective momentum names near highs over broad-based exposure.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | DDOG | SKIP | — | $283.34 → $297.86 stop $257.27 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #2 | AMGN | SKIP | — | $412.84 → $434.00 stop $382.29 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #3 | CTAS | SKIP | — | $206.38 → $217.22 stop $190.70 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #4 | KDP | SKIP | — | $32.66 → $34.29 stop $30.37 |
Half-Kelly sizes this at 0% — the odds carry no edge worth capital. |
| #5 | GEHC | SKIP | — | $68.79 → $72.23 stop $65.49 |
Position cap reached — 74 of 20 slots in use. |
Already open: WMT (to Oct 14), WDAY (to Oct 18), LGEN.L (to Oct 21), SSE.L (to Oct 21), IAG.L (to Oct 22), AAPL (to Oct 22), KGF.L (to Oct 23), DHR (to Oct 24), DCC.L (to Oct 25), PFE (to Oct 28), DPLM.L (to Oct 28), SMIN.L (to Oct 28) … and 62 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Datadog sells software that helps businesses monitor their cloud computing systems and catch problems before they cause outages. The stock has climbed over 23% in the past month and is clearly outpacing the broader tech market, with healthy (not overheated) momentum readings. The main risks are an earnings report landing in just over three weeks that could swing the price sharply, and a notable amount of recent stock selling by company executives.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Amgen is a large biotech company that makes well-known drugs for conditions like arthritis, high cholesterol, and osteoporosis. Its stock has climbed steadily over the past month and is modestly beating the broader market, with technical signals pointing to healthy, sustainable strength rather than a stock that's run too far too fast. The main risk is an earnings report in about three weeks, though the company has beaten estimates for four straight quarters.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 61%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Cintas supplies uniforms, mats, and safety supplies to businesses across North America. The company just reported double-digit revenue and profit growth and raised its full-year financial outlook, which is a strong vote of confidence from management, and the stock sits a bit below its recent peak. The main risk is a pending regulatory review of its planned acquisition of a competitor, which could introduce uncertainty, plus a couple of company insiders selling shares recently.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Keurig Dr Pepper sells coffee and soft drinks, a classic defensive business that people keep buying regardless of the economy. It's one of the safety-focused stocks the market is quietly rotating into right now, trading near its highs with strong recent momentum and a clean streak of earnings beats. The main risk is an earnings report landing inside this 30-day window, which could swing the stock either way.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 60%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
GE HealthCare makes medical imaging machines and diagnostic equipment used in hospitals worldwide. The stock has been quietly recovering and is now squeezed into a tight trading range that often precedes a bigger move, with momentum building faster than the broader market. The main risk is that it's still well below its 52-week high and earnings arrive in about two weeks, so any disappointment could quickly undo the recent gains.
Why the AI likes it
What could go wrong
Calibrated probability: 55% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 12, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 101 NASDAQ 100 constituents and short-listed 24 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.